DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Windlas Biotech Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 3 hrs ago·5 Aug 2026, 8:24 am

Windlas Biotech

Windlas Biotech Limited has announced that it will hold a meeting with analysts and institutional investors. This event is part of the company's standard practice to update the market on its business performance and future outlook.

For investors, this announcement signals that the company is preparing to share detailed insights with the investment community. It offers a chance to hear management's perspective on the company's growth trajectory and strategic plans directly from the source.

Investors should watch for the specific timing of the event and any key takeaways regarding the company's financial health and product pipeline. The company's response to queries during the call will also be important to gauge management's confidence.